119 related articles for article (PubMed ID: 50710)
1. Studies on lymphocyte sensitization to encephalitogenic protein in tumor patients.
Cerni CH; Micksche M
Acta Neuropathol Suppl; 1975; Suppl 6():65-8. PubMed ID: 50710
[TBL] [Abstract][Full Text] [Related]
2. Cellular immunity to encephalitogenic factor in man as measured by the macrophage migration inhibition test: the effects of serum.
Flavell DJ; Potter CW
Br J Cancer; 1978 Jan; 37(1):15-22. PubMed ID: 74259
[TBL] [Abstract][Full Text] [Related]
3. Cellular immunity to myelin basic protein in man and in animal model systems as measured by the macrophage migration inhibition test.
Shelton JB; Potter CW; Carr I
Br J Cancer; 1975 May; 31(5):528-34. PubMed ID: 50855
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte reactivity to allogeneic tumor antigens and myelin basic protein in gastric cancer patients.
Nakajima T; Chikamori M; Isojima K; Iwaguchi T
Gan; 1977 Aug; 68(4):449-57. PubMed ID: 80343
[No Abstract] [Full Text] [Related]
5. Cellular immunity to human basic myelin protein in women with dysplasia and carcinoma in situ of the cervix.
Singer A; Shelton J; Hill S; Potter C
Br J Obstet Gynaecol; 1975 Oct; 82(10):820-5. PubMed ID: 53067
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte sensitization in childhood solid tumours and lymphoblastic leukaemia, measured by electrophoretic mobility test.
Lampert F; Nitzschke U; Zwergel T
Br J Cancer; 1977 Jun; 35(6):844-9. PubMed ID: 68784
[TBL] [Abstract][Full Text] [Related]
7. Immunological tumour profile: organ-specific carcinoma diagnosis in patients employing the macrophage electrophoretic mobility test.
Müller M; Irmscher J; Fischer R; Heidl G; Grossmann H
Cancer Lett; 1977 Jan; 2(3):139-45. PubMed ID: 65215
[TBL] [Abstract][Full Text] [Related]
8. Immunodiagnostics of malignant disease. VI. Electrophoretic mobility test (EMT) in malignant melanoma.
Douwes FR; Spellmann HJ; Mross K; Wolfrum DI
Oncology; 1978; 35(4):163-7. PubMed ID: 81476
[TBL] [Abstract][Full Text] [Related]
9. Simplified cell microelectrophoretic method applied to the macrophage electrophoretic mobility test for cancer diagnosis.
Fike RM; van Oss CJ
Immunol Commun; 1979; 8(2):173-84. PubMed ID: 86499
[TBL] [Abstract][Full Text] [Related]
10. Cell-mediated immunity to encephalitogenic factor (MMI test) in women with cervical dysplasia and carcinoma in situ: the effects of serum.
Flavell DJ; Singer A; Potter CW
Br J Cancer; 1978 Sep; 38(3):396-400. PubMed ID: 81675
[TBL] [Abstract][Full Text] [Related]
11. Electrophoretic mobility (EM)-test for childhood cancer diagnosis.
Nitzschke U; Zwergel T; Lampert F
Eur J Pediatr; 1977 Oct; 126(3):163-73. PubMed ID: 71993
[TBL] [Abstract][Full Text] [Related]
12. [Experiences with the macrophage electrophoresis mobility test (MEM test) in the diagnosis of malignant gynecological diseases].
Günther J
Zentralbl Bakteriol Orig B; 1975; 91(9):529-39. PubMed ID: 52961
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of macrophage electrophoretic mobility (MEM) test as an indicator of cellular immunity in ocular tumours.
Rahi AH; Otiko G; Winder AF
Br J Ophthalmol; 1976 Aug; 60(8):589-93. PubMed ID: 61762
[TBL] [Abstract][Full Text] [Related]
14. Checking of carcinoma patients with the leukocyte migration technique (LMT) under agarose.
Emmrich F; Ambrosius H
Neoplasma; 1978; 25(4):483-91. PubMed ID: 80756
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis: sensitization of a myelin basic protein fragment (peptide T) encephalitogenic to primates. A preliminary report.
Sheremata W; Eylar EH; Cosgrove JB
J Neurol Sci; 1977 Jun; 32(2):255-63. PubMed ID: 69018
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of the macrophage electrophoretic mobility test for cancer.
Lewkonia RM; Kerr EJ; Irvine WJ
Br J Cancer; 1974 Dec; 30(6):532-7. PubMed ID: 4447784
[TBL] [Abstract][Full Text] [Related]
17. Cellular immunity to encephalitogenic factor as measured by macrophage migration inhibition during tumour induction and growth.
Flavell DJ; Goepel J; Potter CW; Carr I
Br J Cancer; 1978 May; 37(5):818-26. PubMed ID: 77674
[TBL] [Abstract][Full Text] [Related]
18. [The phenomenon of blastic transformation of lymphocytes in the immunology of neoplastic diseases].
Zhukhina GE
Vopr Onkol; 1972; 18(6):91-6. PubMed ID: 4559304
[No Abstract] [Full Text] [Related]
19. Studies with the macrophage migration inhibition (MMI) test in patients with malignant disease.
Light PA; Preece AW; Waldron HA
Clin Exp Immunol; 1975 Nov; 22(2):279-84. PubMed ID: 55328
[TBL] [Abstract][Full Text] [Related]
20. The macrophage electrophoretic mobility (MEM) test for the diagnosis of hydatidiform mole and choriocarcinoma. Preliminary report.
Klausch B; Straube W; Hofmann R; Büttner HH; Jenssen HL; Köhler H; Günther J
Ann Chir Gynaecol; 1977; 66(4):209-13. PubMed ID: 71873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
